HSCSW (HeartSciences) PB Ratio: (As of Sep. 10, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HSCSW HeartSciences Inc HSCSW
18 GF Score
Price $0.07
! 10 Warning Signs
View Full Analysis

What is HeartSciences PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-09-10), HeartSciences's share price is $0.0706. HeartSciences's Book Value per Share for the quarter that ended in Apr. 2026 was $0.00. Hence, HeartSciences's PB Ratio of today is .

Warning Sign:

HeartSciences Inc stock PB Ratio (=57.75) is close to 5-year high of 57.75.

The historical rank and industry rank for HeartSciences's PB Ratio or its related term are showing as below:

HSCSW' s PB Ratio Range Over the Past 10 Years
Min: 0.34   Med: 2.53   Max: 57.75
Current: 57.75

During the past 7 years, HeartSciences's highest PB Ratio was 57.75. The lowest was 0.34. And the median was 2.53.

HSCSW's PB Ratio is ranked worse than
99.49% of 784 companies
in the Medical Devices & Instruments industry
Industry Median: 2.135 vs HSCSW: 57.75

During the past 12 months, HeartSciences's average Book Value Per Share Growth Rate was -61.20% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -68.60% per year.

During the past 7 years, the highest 3-Year average Book Value Per Share Growth Rate of HeartSciences was -16.30% per year. The lowest was -68.60% per year. And the median was -42.45% per year.

Back to Basics: PB Ratio


HeartSciences  (NAS:HSCSW) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


HeartSciences PB Ratio Related Terms


HeartSciences PB Ratio Historical Data

* Premium members only.

The historical data trend for HeartSciences's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

HeartSciences PB Ratio Chart

HeartSciences Annual Data
Trend Apr20 Apr21 Apr22 Apr23 Apr24 Apr25 Apr26
PB Ratio
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

HeartSciences Quarterly Data
Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25 Apr25 Jul25 Oct25 Jan26 Apr26
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

HSCSW vs IRIX, ALRTF, ADGM: PB Ratio Comparison

For the Medical Devices subindustry, HeartSciences's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HeartSciences PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, HeartSciences's PB Ratio distribution charts can be found below:

* The bar in red indicates where HeartSciences's PB Ratio falls into.


HSCSW
18GF Score
HeartSciences Inc HSCSW
PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

HeartSciences PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

HeartSciences's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Apr. 2026)
=0.0706/0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


HeartSciences Business Description

Other Exchanges HSCS:USA
Address 550 Reserve Street, Suite 360, Southlake, TX, USA, 76092
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
18GF Score

Get the complete analysis for HSCSW

PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.07
Price